Last update: Aug. 19, 2012
Mild risk possible. Follow up recommended.
Read the Comment.
It is a carbonic anhydrase (CA) inhibitor sulphonamide drug which is used as 1% drops for topical treatment to lower intraocular pressure or glaucoma. EMEA and FDA have informed of very low serum levels found to be bound to CA red blood cells even after oral ingestion. For this reason and because it is usually used as a topical treatment its presence in mother’s milk is unlikely.
Like most ophthalmologic compounds for topical use, a low dose and poor absorption make it compatible with breastfeeding. Pressing conjunctiva sack for a couple of minutes to lessen systemic absorption.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM